Literature DB >> 3232891

[Prevalence of hepatitis caused by A, B and D virus in children].

M Ruiz Moreno1, J García Aguado, V Carreño García, L Alvarez Sala, P Rincón Víctor, M López-Linares del Prado, C Bas Pérez.   

Abstract

The aim of this study was to determine the prevalence due to hepatitis A, B and D viruses infection in children. A total of 286 children from Madrid area with ages ranging between 0 and 13 years were included. The sample was randomized with respect to the sex and age referring to the total population of Madrid. The anti-HAV was positive in 15.16% of cases, with an increasing lineal correlation with age. Any marker of HBV infection was found in 6.6% and HBsAg in 1.4%. There was an exponential correlation between the carrier state and the age, with a maximum at the first year and diminishing thereafter with age. The 21% of the cases with positive HBV-markers were HBsAg carriers. A predominant perinatal and intrafamiliar transmission of HBV was detected. Our results indicate a intermediate prevalence of HBV infection in Spain, suggesting the importance of HBsAg detection in pregnant women. None of the HBV-infected cases had anti-HD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3232891

Source DB:  PubMed          Journal:  An Esp Pediatr        ISSN: 0302-4342


  3 in total

1.  Current prevalence of hepatitis B, A and C in a healthy Spanish population. A seroepidemiological study.

Authors:  R Dal-Ré; L Aguilar; P Coronel
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

2.  Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern Spain.

Authors:  M A Rodriguez-Iglesias; M T Pérez-Gracia; M S Garcia-Valdivia; S Pérez-Ramos
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

3.  A seroepidemiologic study of hepatitis A in Spanish children. Relationship of prevalence to age and socio-environmental factors.

Authors:  J L Morales; L Huber; S Gallego; G Alvarez; J Diez-Delgado; A González; L Aguilar; R Dal-Ré
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.